Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease

• Main Authors: Victor Gustavo Balera Brito (Author), Mariana Sousa Patrocinio (Author), Maria Carolina Linjardi (Author), Ayná Emanuelli Alves Barreto (Author), Sabrina CT Frasnelli (Author), Vanessa Lara (Author), Carlos Ferreira Santos (Author), Sandra Helena Penha Oliveira (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Periodontal disease (PD) is a prevalent inflammatory disease with the most severe consequence being the loss of the alveolar bone and teeth. We therefore aimed to evaluate the effects of telmisartan (TELM), an angiotensin II type 1 receptor (Agtr1) antagonist, on the PD-induced alveolar bone loss, i...